Wall Street brokerages expect U.S. Physical Therapy, Inc. (NYSE:USPH) to report sales of $121.47 million for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for U.S. Physical Therapy’s earnings, with the lowest sales estimate coming in at $119.00 million and the highest estimate coming in at $124.67 million. U.S. Physical Therapy posted sales of $113.12 million during the same quarter last year, which would indicate a positive year over year growth rate of 7.4%. The company is scheduled to announce its next quarterly earnings results before the market opens on Thursday, November 7th.
On average, analysts expect that U.S. Physical Therapy will report full-year sales of $489.73 million for the current fiscal year, with estimates ranging from $484.00 million to $496.99 million. For the next financial year, analysts anticipate that the firm will report sales of $521.19 million, with estimates ranging from $509.70 million to $539.77 million. Zacks’ sales calculations are a mean average based on a survey of research firms that that provide coverage for U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.81 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.81. U.S. Physical Therapy had a return on equity of 19.19% and a net margin of 6.22%. The business had revenue of $126.40 million during the quarter, compared to analysts’ expectations of $124.86 million. During the same period in the previous year, the firm posted $0.73 earnings per share. The company’s revenue was up 9.8% on a year-over-year basis.
Shares of NYSE USPH traded up $2.33 during trading on Friday, reaching $131.90. The stock had a trading volume of 529 shares, compared to its average volume of 83,426. U.S. Physical Therapy has a fifty-two week low of $98.69 and a fifty-two week high of $138.58. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.88 and a current ratio of 1.88. The business’s 50-day moving average price is $132.03 and its 200-day moving average price is $122.17. The company has a market cap of $1.64 billion, a P/E ratio of 49.67, a PEG ratio of 3.57 and a beta of 1.12.
In other news, COO Graham D. Reeve sold 952 shares of the business’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $134.00, for a total value of $127,568.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Christopher J. Reading sold 601 shares of the business’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $135.39, for a total value of $81,369.39. The disclosure for this sale can be found here. Insiders sold a total of 22,803 shares of company stock valued at $3,067,830 over the last three months. Company insiders own 2.50% of the company’s stock.
A number of institutional investors and hedge funds have recently bought and sold shares of USPH. TCG Advisors LP purchased a new stake in U.S. Physical Therapy during the 1st quarter valued at approximately $25,000. NumerixS Investment Technologies Inc purchased a new stake in U.S. Physical Therapy during the 2nd quarter valued at approximately $61,000. Ladenburg Thalmann Financial Services Inc. raised its stake in U.S. Physical Therapy by 74.0% during the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 548 shares of the company’s stock valued at $67,000 after acquiring an additional 233 shares during the last quarter. Tower Research Capital LLC TRC purchased a new position in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $91,000. Finally, Resources Investment Advisors LLC. raised its stake in shares of U.S. Physical Therapy by 96.6% during the 2nd quarter. Resources Investment Advisors LLC. now owns 816 shares of the company’s stock worth $100,000 after buying an additional 401 shares in the last quarter.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading: What is the Fibonacci sequence?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.